Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v23-EN Version v13-FR
Language English French
Date Updated 2022-01-08 2021-12-14
Drug Identification Number 02182882 02182882
Brand name COZAAR COZAAR
Common or Proper name losartan potassium tablets losartan potassium tablets
Company Name ORGANON CANADA INC. ORGANON CANADA INC.
Ingredients LOSARTAN POTASSIUM LOSARTAN POTASSIUM
Strength(s) 100MG 100MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 30 30
ATC code C09CA C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2021-10-15 2021-10-15
Estimated end date 2022-01-17 2021-12-17
Actual end date 2022-01-07
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Orders partially released Oct 27 and Dec 17,2021 Orders partially released Oct 27
Health Canada comments